Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and inter...
TIANYU PHARM: Net profit in the third quarter was 71.4211 million yuan, a year-on-year increase of 123.90%
TIANYU PHARM: Candesartan Cilexetil Tablets have completed drug registration
TIANYU PHARM released its performance for the first half of the year, with a net profit attributable to the parent company of 150 million yuan, an increase of 180.96%
The A-share chemical pharmaceutical sector continues to rise, with TIBET AIM PHARM hitting the limit up, and TIANYU PHARM, CSBIO, Zhendong Pharmaceutical, Menovo, JENKEM, and GuangShengTang following suit
TIANYU PHARM signed a cooperation agreement with Heilongjiang Fengyou Biotechnology Development Co., Ltd
TIANYU PHARM: The company's bulk lisinopril raw material has obtained the CEP certificate